STOP Fentanyl and Xylazine Act

Overview: HR 1563, the "STOP Fentanyl and Xylazine Act", was introduced in the House of Representatives on February 25, 2025.

Purpose and Intent: The bill aims to address the growing public health crisis caused by the proliferation of fentanyl and xylazine, two highly potent and dangerous synthetic opioids. The legislation seeks to enhance law enforcement efforts, improve data collection, and expand access to treatment and prevention programs.

Key Provisions:
- Increases penalties for the manufacture, distribution, and possession of fentanyl and xylazine
- Establishes a grant program to support state and local law enforcement in combating the opioid crisis
- Requires the Centers for Disease Control and Prevention (CDC) to improve data collection and reporting on fentanyl and xylazine-related overdoses
- Expands access to evidence-based treatment and recovery services for individuals struggling with opioid addiction

Affected Parties and Impacts: The bill would impact law enforcement agencies, public health authorities, healthcare providers, and individuals affected by the opioid crisis. It aims to reduce the availability of these dangerous substances and increase access to effective treatment and prevention programs.

Procedural and Timeline Considerations: The bill has been introduced in the House and is currently pending further legislative action.